These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 33188837)

  • 21. lncRNA RPL34-AS1 inhibits cell proliferation and invasion while promoting apoptosis by competitively binding miR-3663-3p/RGS4 in papillary thyroid cancer.
    Ji L; Fan X; Zhou F; Gu J; Deng X
    J Cell Physiol; 2020 Apr; 235(4):3669-3678. PubMed ID: 31587286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-99a-3p/GRP94 axis affects metastatic progression of human papillary thyroid carcinoma by regulating ITGA2 expression and localization.
    Gao Y; Pan Y; Wang T; Yao Y; Yuan W; Zhu X; Wang K
    Acta Biochim Biophys Sin (Shanghai); 2021 Dec; 53(12):1650-1661. PubMed ID: 34687203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-130a-3p impedes the progression of papillary thyroid carcinoma through downregulation of KPNB1 by targeting PSME3.
    Wang Y; Xu J; Zhu X; Kuang H
    Endocrine; 2023 Oct; 82(1):96-107. PubMed ID: 37166548
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MiR-758-3p regulates papillary thyroid cancer cell proliferation and migration by targeting TAB1.
    Chen J; Xu Z; Yu C; Wu Z; Yin Z; Fang F; Chen B
    Pharmazie; 2019 Apr; 74(4):235-238. PubMed ID: 30940308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-142-3P suppresses the progression of papillary thyroid carcinoma by targeting FN1 and inactivating FAK/ERK/PI3K signaling.
    Jiang Y; Liu Y; Zhang Y; Ouyang J; Feng Y; Li S; Wang J; Zhang C; Tan L; Zhong J; Zou L
    Cell Signal; 2023 Sep; 109():110792. PubMed ID: 37406787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. microRNA-124-3p inhibits tumourigenesis by targeting mitogen-activated protein kinase 4 in papillary thyroid carcinoma.
    Sun Y; Zhang L; Zhang S
    Cell Biochem Funct; 2020 Dec; 38(8):1017-1024. PubMed ID: 32495394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MiR-548b-3p inhibits proliferation and migration of breast cancer cells by targeting MDM2.
    Sha MX; Huang XW; Yin Q
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3105-3112. PubMed ID: 32271428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Upregulation of microRNA-143-3p induces apoptosis and suppresses proliferation, invasion, and migration of papillary thyroid carcinoma cells by targeting MSI2.
    Wang ZL; Wang C; Liu W; Ai ZL
    Exp Mol Pathol; 2020 Feb; 112():104342. PubMed ID: 31738908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MiR-548c-3p suppressed the progression of papillary thyroid carcinoma via inhibition of the HIF1α-mediated VEGF signaling pathway.
    Du Y; Zhu J; Chu BF; Yang YP; Zhang SL
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6570-6578. PubMed ID: 31378898
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-31 inhibits papillary thyroid carcinoma cell biological progression by directly targeting SOX11 and regulating epithelial-to-mesenchymal transition, ERK and Akt signaling pathways.
    Wang Y; Liu BG; Zhou CX
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5863-5873. PubMed ID: 31298337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circ_0000144 acts as a miR-1178-3p decoy to promote cell malignancy and angiogenesis by increasing YWHAH expression in papillary thyroid cancer.
    Ma Y; Yang D; Guo P
    J Otolaryngol Head Neck Surg; 2022 Jul; 51(1):28. PubMed ID: 35902926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. STAT3-induced upregulation of lncRNA ABHD11-AS1 promotes tumour progression in papillary thyroid carcinoma by regulating miR-1301-3p/STAT3 axis and PI3K/AKT signalling pathway.
    Wen J; Wang H; Dong T; Gan P; Fang H; Wu S; Li J; Zhang Y; Du R; Zhu Q
    Cell Prolif; 2019 Mar; 52(2):e12569. PubMed ID: 30657221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long non-coding RNA TTN-AS1 facilitates tumorigenesis of papillary thyroid cancer through modulating the miR-153-3p/ZNRF2 axis.
    Cui Z; Luo Z; Lin Z; Shi L; Hong Y; Yan C
    J Gene Med; 2019 May; 21(5):e3083. PubMed ID: 30811764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-222 Promotes Invasion and Metastasis of Papillary Thyroid Cancer Through Targeting Protein Phosphatase 2 Regulatory Subunit B Alpha Expression.
    Huang Y; Yu S; Cao S; Yin Y; Hong S; Guan H; Li Y; Xiao H
    Thyroid; 2018 Sep; 28(9):1162-1173. PubMed ID: 29882471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-146a targets PRKCE to modulate papillary thyroid tumor development.
    Zhang X; Li D; Li M; Ye M; Ding L; Cai H; Fu D; Lv Z
    Int J Cancer; 2014 Jan; 134(2):257-67. PubMed ID: 23457043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estrogen-mediated DNMT1 and DNMT3A recruitment by EZH2 silences miR-570-3p that contributes to papillary thyroid malignancy through DPP4.
    Hu X; Ye Q; Lu H; Wu Z; Chen S; Zheng R
    Clin Epigenetics; 2024 Jun; 16(1):81. PubMed ID: 38890707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CircRNA circ-ITCH suppresses papillary thyroid cancer progression through miR-22-3p/CBL/β-catenin pathway.
    Wang M; Chen B; Ru Z; Cong L
    Biochem Biophys Res Commun; 2018 Sep; 504(1):283-288. PubMed ID: 30190130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The lncRNA SNHG3 accelerates papillary thyroid carcinoma progression via the miR-214-3p/PSMD10 axis.
    Sui G; Zhang B; Fei D; Wang H; Guo F; Luo Q
    J Cell Physiol; 2020 Oct; 235(10):6615-6624. PubMed ID: 32048306
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-625-3p promotes the proliferation, migration and invasion of thyroid cancer cells by up-regulating astrocyte elevated gene 1.
    Fang L; Kong D; Xu W
    Biomed Pharmacother; 2018 Jun; 102():203-211. PubMed ID: 29558717
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circ_0002111 modulates the growth process of papillary thyroid carcinoma cells by targeting the miR-363-3p/HMGB1 axis.
    Zhang Z; Mo Y; Wu L; Wang X; Liao G; Tan W; Li D
    Anticancer Drugs; 2022 Oct; 33(9):923-934. PubMed ID: 36136992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.